ArticleEuropean journal of medicinal chemistry2018

Novel selective thiadiazine DYRK1A inhibitor lead scaffold with human pancreatic β-cell proliferation activity.

Kunal Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.